111 related articles for article (PubMed ID: 11842975)
1. Nephroblastoma. DNA characteristics and their modifications induced by prenephrectomy chemotherapy: a cytofluorimetric study.
Camassei FD; Ferlini C; Jenkner A; Bosman C; Biselli R; Donfrancesco A; Boldrini R
Pediatr Pathol Mol Med; 2002; 21(1):15-23. PubMed ID: 11842975
[TBL] [Abstract][Full Text] [Related]
2. Wilms tumors: relationship of nuclear deoxyribonucleic acid ploidy to patient survival.
Rainwater LM; Hosaka Y; Farrow GM; Kramer SA; Kelalis PP; Lieber MM
J Urol; 1987 Oct; 138(4 Pt 2):974-7. PubMed ID: 2821294
[TBL] [Abstract][Full Text] [Related]
3. The relationship of deoxyribonucleic acid content to conventional prognostic factors in Wilms tumor.
Layfield LJ; Ritchie AW; Ehrlich R
J Urol; 1989 Oct; 142(4):1040-3. PubMed ID: 2552184
[TBL] [Abstract][Full Text] [Related]
4. DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis.
Gururangan S; Dorman A; Ball R; Curran B; Leader M; Breatnach F; O'Meara A
J Clin Pathol; 1992 Jun; 45(6):498-501. PubMed ID: 1320635
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidy.
Li P; Yokomori K; Tsuchida Y; Fujita M; Shimizu K; Tanaka E; Pianovski MA; Takemura T
Tumour Biol; 1995; 16(6):385-93. PubMed ID: 7569685
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
[TBL] [Abstract][Full Text] [Related]
7. The measurement of DNA content in Wilms' tumor and its clinical significance.
Chen F; Li ZC; Ge RQ; Liu GH; Cai W; Zhang ZD
J Pediatr Surg; 1994 Apr; 29(4):548-50. PubMed ID: 8014813
[TBL] [Abstract][Full Text] [Related]
8. Regional DNA content heterogeneity in Wilms' tumor: incidence and potential clinical relevance.
Yildiz I; Jaffe N; Aksoy F; el-Naggar AK
Anticancer Res; 1994; 14(3B):1365-9. PubMed ID: 8067707
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of deoxyribonucleic acid ploidy and proliferation in choroid plexus tumors.
Coons SW; Johnson PC; Haskett D; Rider R
Neurosurgery; 1992 Nov; 31(5):850-6; discussion 856. PubMed ID: 1436408
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
11. Thirty-year population-based review of childhood renal tumours with an assessment of prognostic features including tumour DNA characteristics.
Barrantes JC; Muir KR; Toyn CE; Parkes SE; Cameron AH; Marsden HB; Raafat F; Mann JR
Med Pediatr Oncol; 1993; 21(1):24-30. PubMed ID: 8381201
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer.
Salud A; Porcel JM; Raikundalia B; Camplejohn RS; Taub NA
J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of nephroblastomas and related neoplasms.
Schmidt D; Wiedemann B; Keil W; Sprenger E; Harms D
Cancer; 1986 Dec; 58(11):2494-500. PubMed ID: 3021318
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
20. Deoxyribonucleic acid ploidy and S-phase fraction are not significant prognostic factors for patients with cervical cancer.
Jelen I; Valente PT; Gautreaux L; Clark GM
Am J Obstet Gynecol; 1994 Dec; 171(6):1511-6; discussion 1516-8. PubMed ID: 7802060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
